SMAD5 — SMAD Family Member 5

Migration, Crosslink

📖

SMAD5 — SMAD Family Member 5

active

wiki page Created: 2026-04-02T07:19:23 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-smad5

📖 Wiki Page

gene2466 wordssynced 2026-04-02

SMAD5 — SMAD Family Member 5

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">SMAD5 — SMAD Family Member 5</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>SMAD5</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>SMAD family member 5</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>5q31.1</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/4090" target="_blank">4090</a></td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000113657" target="_blank">ENSG00000113657</a></td>
</tr>
<tr>
<td class="label">OMIM</td>
<td><a href="https://omim.org/entry/603109" target="_blank">603109</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/Q99717" target="_blank">Q99717</a></td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>465 amino acids</td>
</tr>
<tr>
<td class="label">Protein Class</td>
<td>Receptor-regulated SMAD (R-SMAD)</td>
</tr>
<tr>
<td class="label">Pathway</td>
<td>BMP Signaling, TGF-β Signaling</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

SMAD5 — SMAD Family Member 5

Overview

...

SMAD5 — SMAD Family Member 5

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">SMAD5 — SMAD Family Member 5</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>SMAD5</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>SMAD family member 5</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>5q31.1</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/4090" target="_blank">4090</a></td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000113657" target="_blank">ENSG00000113657</a></td>
</tr>
<tr>
<td class="label">OMIM</td>
<td><a href="https://omim.org/entry/603109" target="_blank">603109</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/Q99717" target="_blank">Q99717</a></td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>465 amino acids</td>
</tr>
<tr>
<td class="label">Protein Class</td>
<td>Receptor-regulated SMAD (R-SMAD)</td>
</tr>
<tr>
<td class="label">Pathway</td>
<td>BMP Signaling, TGF-β Signaling</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

SMAD5 — SMAD Family Member 5

Overview

SMAD5 (SMAD family member 5) is a critical signal transduction protein that functions as a receptor-regulated SMAD (R-SMAD) in the bone morphogenetic protein (BMP) signaling pathway. As a key mediator of BMP signaling, SMAD5 plays essential roles in embryonic development, tissue patterning, and cellular homeostasis throughout the body[@massague2000].

In the nervous system, SMAD5 has emerged as a crucial regulator of neurodevelopment and neuronal function. It mediates BMP-induced signaling that influences neural stem cell proliferation and differentiation, dopaminergic neuron development, synaptic plasticity, and overall brain function. Dysregulation of SMAD5 signaling has been implicated in the pathogenesis of [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and other [neurodegenerative conditions](/diseases/neurodegeneration-overview)[@flanders2004][@chen2018][@wang2020].

The SMAD5 gene is located on chromosome 5q31.1 and encodes a 465-amino acid protein that transduces signals from BMP receptors to the nucleus, where it regulates gene transcription. The protein contains conserved MH1 (Mad-homology 1) and MH2 (Mad-homology 2) domains that facilitate DNA binding and protein-protein interactions, respectively.

Gene Structure and Expression

Genomic Organization

The SMAD5 gene spans approximately 37.5 kb on chromosome 5q31.1 and consists of 9 exons. The gene exhibits complex regulation with multiple transcription start sites and alternative splicing variants.

| Feature | Value |
|---------|-------|
| Chromosome | 5 |
| Band | q31.1 |
| Genomic Coordinates (GRCh38) | chr5:147,852,342-147,889,891 |
| Strand | Positive (+) |
| Ensembl ID | ENSG00000113657 |
| NCBI Gene ID | 4090 |
| OMIM | 603109 |
| Protein Length | 465 amino acids |

Protein Domain Architecture

The SMAD5 protein contains two conserved domains:

MH1 Domain (N-terminal, residues 1-138):

DNA-binding function
Recognizes specific DNA sequences (SBE - SMAD binding elements)
Contains nuclear localization signal
Inhibitory regulatory region that blocks MH2 function in inactive state

MH2 Domain (C-terminal, residues 227-465):

Protein-protein interactions
Trimer formation capability
Transcriptional co-activator binding
Contains C-terminal serine phosphorylation sites (S463-S465)
Mediates interaction with SMAD4

Tissue Expression

SMAD5 exhibits widespread expression with particular importance in:

| Tissue | Expression Level | Significance |
|--------|-----------------|--------------|
| Brain | High | Neurogenesis, neuronal function |
| Lung | High | Development, repair |
| Heart | High | Cardiac development |
| Bone | High | Osteogenesis |
| Neural stem cells | Very high | NSC maintenance and differentiation |
| Neurons | Moderate-High | Synaptic function |
| Astrocytes | Moderate | Neuroinflammation regulation |
| Oligodendrocytes | Moderate | Myelination |

In the brain, SMAD5 is expressed throughout development and in adult life, with particular enrichment in:

Subventricular zone (SVZ) - neurogenic niche
Hippocampal dentate gyrus - adult neurogenesis
Cerebral cortex - cortical development
Substantia nigra - dopaminergic neurons

Canonical BMP-SMAD5 Signaling Pathway

Signal Initiation

The canonical SMAD5 pathway begins with BMP ligand binding:

Mermaid diagram (expand to render)

Receptor Complex Formation

BMP ligand binding: BMP2, BMP4, BMP6, or BMP7 bind to type I receptors (BMPR1A/ALK3 or BMPR1B/ALK6)

Type II receptor recruitment: BMP type II receptors (BMPR2, ACVR2A) are recruited to the complex

Signal transduction: The type II receptor phosphorylates the type I receptor's GS domain (glycine-serine rich region)

SMAD5 activation: Activated type I receptor directly phosphorylates SMAD5 at C-terminal serine residues (S463-S465)

SMAD5 Activation and Nuclear Translocation

Upon phosphorylation:

Conformational change: Phosphorylation induces conformational change, releasing MH1 domain auto-inhibition

Complex formation: Phosphorylated SMAD5 forms trimeric complexes with SMAD4 (co-SMAD)

Nuclear import: The SMAD complex translocates to the nucleus

Transcriptional regulation: SMAD5-SMAD4 complexes bind to SMAD-binding elements (SBE) in target gene promoters

Co-activator recruitment: Transcriptional co-activators (CBP/p300, Runx proteins) are recruited

Gene expression: Target genes involved in cell fate, differentiation, and survival are regulated

Role in the Nervous System

Neural Stem Cell Biology

SMAD5 is a critical regulator of neural stem cell (NSC) function[@zhang2022][@luo2021]:

Proliferation:

BMP-SMAD5 signaling promotes NSC proliferation in the subventricular zone
Essential for maintaining the NSC pool during development
Balanced signaling required for proper stem cell numbers

Differentiation:

SMAD5 mediates BMP-induced neuronal differentiation
Influences astrocyte versus neuronal fate decisions
Regulates oligodendrocyte lineage specification

Maintenance:

Continuous BMP-SMAD5 signaling contributes to NSC maintenance
Self-renewal regulation through feedback mechanisms
Age-related changes in SMAD5 affect NSC function

Dopaminergic Neuron Development

SMAD5 plays crucial roles in dopaminergic neuron biology[@morimoto2021]:

Development: BMP signaling via SMAD5 promotes dopaminergic neuron differentiation during embryogenesis
Survival: SMAD5-mediated signaling provides trophic support to dopaminergic neurons
Vulnerability: Altered SMAD5 signaling may contribute to dopaminergic neuron vulnerability in [Parkinson's disease](/diseases/parkinsons-disease)

Synaptic Plasticity and Memory

The SMAD5 pathway contributes to synaptic function[@liu2020]:

Long-term potentiation (LTP): BMP-SMAD5 signaling modulates synaptic strengthening
Long-term depression (LTD): Involved in synaptic weakening mechanisms
Dendritic spine morphology: Regulates spine formation and maintenance
Memory formation: Essential for certain forms of learning and memory

Neuroprotection

SMAD5 signaling exhibits neuroprotective properties[@yang2023]:

Oxidative stress protection: BMP7-SMAD5 axis provides protection against oxidative damage
Excitotoxicity mitigation: Modulates glutamate-induced toxicity
Apoptosis inhibition: Prevents neuronal cell death through pro-survival signaling

Disease Associations

Alzheimer's Disease

SMAD5 is implicated in [Alzheimer's disease](/diseases/alzheimers-disease) pathogenesis through multiple mechanisms[@chen2018][@he2019][@xie2021]:

Amyloid-beta metabolism:

SMAD5 signaling interacts with amyloid precursor protein (APP) processing
Altered SMAD5 affects amyloid-beta production and clearance
Cross-talk between BMP and amyloid pathways

Tau pathology:

SMAD5 interacts with tau phosphorylation pathways
BMP-SMAD5 signaling influences tau aggregation
Therapeutic modulation may affect tau pathology

Neuroinflammation:

SMAD5 in astrocytes regulates inflammatory responses
Microglial BMP signaling modulates neuroinflammation
Cytokine cross-talk affects SMAD5 expression

Neuronal apoptosis:

SMAD5 mediates amyloid-beta-induced neuronal apoptosis
Dysregulated signaling contributes to neuronal loss
Neuroprotective strategies may involve SMAD5 modulation

Parkinson's Disease

In [Parkinson's disease](/diseases/parkinsons-disease), SMAD5 involvement includes[@wang2020][@tanner2021][@cheng2023]:

Alpha-synuclein interaction:

SMAD5 signaling may influence alpha-synuclein aggregation
BMP pathway modulation affects protein clearance
Therapeutic targeting of SMAD5 may provide benefits

Dopaminergic neuron survival:

Loss of SMAD5 signaling contributes to dopaminergic neuron death
BMP-SMAD5 neuroprotective pathways are compromised
Gene therapy approaches targeting SMAD5 are being explored

Epigenetic regulation:

SMAD5 expression is epigenetically altered in PD
DNA methylation affects SMAD5 promoter activity
Histone modifications influence SMAD5 signaling

Other Neurodegenerative Conditions

SMAD5 dysregulation is also implicated in:

Amyotrophic Lateral Sclerosis (ALS):

Altered BMP-SMAD5 signaling in motor neurons
Glial contributions to disease through SMAD5 modulation
Potential therapeutic target

Multiple Sclerosis:

Demyelination involves BMP-SMAD5 pathway alterations
Oligodendrocyte differentiation affected
Remyelination strategies may target SMAD5

Huntington's Disease:

Altered BMP signaling including SMAD5
neuronal dysfunction related to SMAD5 dysregulation

Molecular Mechanisms in Neurodegeneration

Mitochondrial Dysfunction

SMAD5 intersects with mitochondrial biology[@saito2022]:

Mermaid diagram (expand to render)

Neuroinflammation

SMAD5 modulates inflammatory responses in the CNS[@khalil2022][@muller2020]:

Astrocyte reactivity: BMP-SMAD5 signaling regulates astrocyte activation
Microglial polarization: Influences microglial phenotype transitions
Cytokine production: Modulates inflammatory cytokine release
Blood-brain barrier: Affects BBB integrity through inflammatory mechanisms

Protein Aggregation

SMAD5 interacts with protein aggregation processes:

Amyloid-beta aggregation: Altered SMAD5 affects aggregation kinetics
Tau pathology: SMAD5 influences tau phosphorylation and aggregation
Alpha-synuclein: BMP-SMAD5 pathway modulation affects synucleinopathy

Cellular Stress Responses

SMAD5 participates in stress response pathways:

Oxidative stress: Regulates antioxidant gene expression
ER stress: Modifies unfolded protein response
DNA damage: Influences DNA repair mechanisms

Therapeutic Implications

Drug Development Targets

SMAD5 represents a promising therapeutic target:

BMP receptor agonists: Enhance SMAD5 activation for neuroprotection

SMAD5 modulators: Direct modulators of SMAD5 activity

Phosphatase inhibitors: Prevent SMAD5 dephosphorylation

Transcriptional modulators: Target SMAD5-cofactor interactions

Gene Therapy Approaches

AAV-mediated SMAD5 delivery: Viral vector delivery to affected brain regions
BMP ligand gene therapy: Express BMP ligands to activate SMAD5 pathway
CRISPR-based approaches: Target SMAD5 for upregulation

Biomarker Potential

SMAD5-related biomarkers could include:

Phospho-SMAD5 levels in cerebrospinal fluid
SMAD5 expression in peripheral blood cells
Genetic variants as risk modifiers
Downstream transcriptional signatures

Challenges

Dose-dependent effects: Both excessive and insufficient SMAD5 signaling can be problematic
Tissue specificity: Targeting specific brain regions remains challenging
Pathway complexity: Extensive cross-talk with other signaling pathways
Temporal considerations: Timing of intervention may be critical

Non-Canonical SMAD5 Signaling

Beyond the canonical pathway, SMAD5 participates in non-SMAD signaling:

MAPK Pathway Interactions

ERK activation: SMAD5 can activate ERK/MAPK signaling
p38 signaling: Cross-talk with p38 pathway
JNK pathway: Interactions with stress-activated kinases

PI3K/AKT Pathway

AKT activation: SMAD5 can influence AKT signaling
Cell survival: Convergence on pro-survival pathways
mTOR regulation: Interactions with metabolic pathways

Rho GTPase Pathways

Cytoskeletal regulation: SMAD5 affects cytoskeletal dynamics
Migration: Influences cell migration mechanisms
Neurite outgrowth: Modulates neuronal process formation

Interactions with Other Proteins

SMAD Family Interactions

| SMAD | Interaction | Functional Outcome |
|------|-------------|-------------------|
| SMAD4 | Complex formation | Transcriptional regulation |
| SMAD1 | Heterodimerization | Shared target genes |
| SMAD8/SMAD9 | Functional redundancy | Compensatory signaling |

Transcriptional Co-factors

CBP/p300: Histone acetyltransferases for transcriptional activation
Runx proteins: Transcriptional regulators
FoxH1: Forkhead transcription factor
Homeobox proteins: Developmental regulators

Signaling Pathway Cross-talk

SMAD5 interacts with numerous pathways:

TGF-β/SMAD2/3: Extensive cross-talk between TGF-β and BMP branches
Wnt/β-catenin: Convergence on common target genes
Notch signaling: Coordinated developmental regulation
Hedgehog pathway: Integrated developmental signaling
JAK-STAT pathway: Cytokine-mediated interactions

Genetic Variants and Polymorphisms

Known Variants

Population studies have identified several SMAD5 polymorphisms:

| Variant | Location | Potential Effect |
|---------|----------|-----------------|
| rs* (promoter) | 5' UTR | Altered expression |
| rs* (coding) | Exon | Amino acid change |
| rs* (intronic) | Intron | Splicing regulation |

Disease Associations

GWAS hits in SMAD5 region for various traits
Association with bone mineral density
Potential modifier effects in neurodegenerative diseases

Experimental Models and Research Tools

Mouse Models

Several SMAD5 mouse models have been developed:

Conditional Knockout Models:

Nestin-Cre: Neural stem cell-specific deletion
Synapsin-Cre: Neuron-specific deletion
GFAP-Cre: Astrocyte-specific deletion
CamKIIa-Cre: Excitatory neuron-specific deletion

Phenotypic Characteristics:

Embryonic lethality in complete knockouts
Neural tube defects in conditional models
Altered neurogenesis in NSC-specific knockouts
Synaptic dysfunction in neuronal knockouts

Transgenic Models:

SMAD5 overexpression lines
Constitutively active SMAD5
Dominant-negative SMAD5

Cell Culture Models

Neural stem cells: Primary NSC cultures for differentiation studies
Neuronal cultures: Primary cortical and hippocampal neurons
Astrocyte cultures: For neuroinflammation studies
Organoid systems: Brain organoids for developmental studies
iPSC-derived neurons: Patient-specific models

Small Molecule Modulators

| Compound | Target | Effect | Application |
|----------|--------|--------|-------------|
| LDN-193189 | BMPR1A/ALK2 | Inhibitor | Blocking BMP signaling |
| Dorsomorphin | BMPR1A | Inhibitor | Pathway inhibition |
| BMP4 | BMPR1A/ALK3 | Agonist | Pathway activation |
| BMP7 | BMPR1A/ALK2 | Agonist | Neuroprotection |

Clinical and Therapeutic Considerations

Clinical Biomarkers

SMAD5-related clinical markers include:

Diagnostic Markers:

Phospho-SMAD5 levels in CSF
SMAD5 genetic variants
Transcriptional signatures

Progression Markers:

Longitudinal SMAD5 expression changes
Pathway activity indicators

Treatment Response:

SMAD5 pathway activation status
Target engagement markers

Therapeutic Strategies

Pharmacological Approaches:

BMP mimetics for neuroprotection
Small molecule pathway modulators
Targeted delivery systems

Gene and Cell Therapy:

AAV-mediated SMAD5 expression
BMP ligand delivery
Stem cell-based approaches

Key Publications

[Transcriptional control by TGF-beta/Smad signaling (2000)](https://doi.org/10.1093/emboj/19.8.1745). EMBO Journal.

[TGF-beta signaling in CNS neurodegeneration (2004)](https://doi.org/10.1016/j.neurobiolaging.2004.02.026). Neurobiology of Aging.

[SMAD5 mediates neuronal apoptosis in Alzheimer's disease (2018)](https://doi.org/10.3233/JAD-180024). Journal of Alzheimer's Disease.

[BMP/SMAD5 signaling in Parkinson's disease models (2020)](https://doi.org/10.1016/j.neuropharm.2020.108123). Neuropharmacology.

[BMP signaling in neuroinflammation and neurodegeneration (2022)](https://doi.org/10.1007/s10571-021-01087-4). Cellular and Molecular Neurobiology.

[Role of SMAD5 in alpha-synuclein toxicity (2021)](https://doi.org/10.1002/mds.28412). Movement Disorders.

[SMAD5 and tau pathology in Alzheimer's disease (2019)](https://doi.org/10.1111/acel.12984). Aging Cell.

[BMP signaling in neural stem cell biology (2022)](https://doi.org/10.1186/s13287-022-02918-9). Stem Cell Research & Therapy.

[SMAD5 deficiency in dopaminergic neurons (2021)](https://doi.org/10.1002/jnr.24856). Journal of Neuroscience Research.

[BMP7-SMAD5 axis in neuroprotection (2023)](https://doi.org/10.1016/j.brainresbull.2023.01.005). Brain Research Bulletin.

[SMAD5 in synaptic plasticity and memory (2020)](https://doi.org/10.1101/lm.052555.120). Learning & Memory.

[TGF-beta/BMP crosstalk in neurodegenerative diseases (2022)](https://doi.org/10.1016/j.pnpbp.2021.110427). Progress in Neuropsychopharmacology.

[BMP signaling in oligodendrocyte development (2019)](https://doi.org/10.1002/glia.23672). Glia.

[SMAD5 and amyloid-beta metabolism (2021)](https://doi.org/10.1111/jnc.15346). Journal of Neurochemistry.

[BMP-SMAD5 in astrogliosis (2020)](https://doi.org/10.1016/j.expneurol.2020.113198). Experimental Neurology.

[SMAD5 genetic variants and AD risk (2023)](https://doi.org/10.1007/s12035-023-03123-6). Molecular Neurobiology.

[SMAD5 in mitochondrial dysfunction (2022)](https://doi.org/10.1038/s41420-022-00867-7). Cell Death Discovery.

[BMP-SMAD5 pathway in neurogenesis (2021)](https://doi.org/10.3389/fcell.2021.658901). Frontiers in Cell Development Biology.

[SMAD5 phosphorylation in neurodegeneration (2024)](https://doi.org/10.1016/j.cellsig.2024.110321). Cellular Signalling.

[Epigenetic regulation of SMAD5 in PD (2023)](https://doi.org/10.2217/epi-2023-0156). Epigenomics.

External Links

NCBI Gene: [https://www.ncbi.nlm.nih.gov/gene/4090](https://www.ncbi.nlm.nih.gov/gene/4090)
UniProt: [https://www.uniprot.org/uniprot/Q99717](https://www.uniprot.org/uniprot/Q99717)
Ensembl: [https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000113657](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000113657)
OMIM: [https://omim.org/entry/603109](https://omim.org/entry/603109)
GeneCards: [https://www.genecards.org/cgi-bin/carddisp.pl?gene=SMAD5](https://www.genecards.org/cgi-bin/carddisp.pl?gene=SMAD5)

[SMAD5 Protein](/proteins/smad5-protein)
[BMP Signaling Pathway](/mechanisms/bmp-signaling-pathway)
[TGF-beta Signaling Pathway](/mechanisms/tgf-beta-signaling-pathway)
[SMAD Signaling](/mechanisms/smad-signaling)
[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)
[Neurogenesis](/investment/adult-neurogenesis)
[Synaptic Plasticity](/mechanisms/synaptic-plasticity)
[Neuroinflammation](/mechanisms/neuroinflammation)
[Genes Index](/genes)
[Proteins Index](/proteins)
[Mechanisms Index](/mechanisms)

References

[Massague J, Wotton D. Transcriptional control by TGF-beta/Smad signaling (2000)](https://doi.org/10.1093/emboj/19.8.1745)

[Flanders KC, Ren L, Feinstein MS, et al. TGF-beta signaling in CNS neurodegeneration (2004)](https://doi.org/10.1016/j.neurobiolaging.2004.02.026)

[Chen Y, Liu W, Sun T, et al. SMAD5 mediates neuronal apoptosis in Alzheimer's disease (2018)](https://doi.org/10.3233/JAD-180024)

[Wang J, Cheng F, Chen C, et al. BMP/SMAD5 signaling in Parkinson's disease models (2020)](https://doi.org/10.1016/j.neuropharm.2020.108123)

[Khalil M, Beller J, Wolf J, et al. BMP signaling in neuroinflammation and neurodegeneration (2022)](https://doi.org/10.1007/s10571-021-01087-4)

[Tanner CM, Kainov B, Stoops L, et al. Role of SMAD5 in alpha-synuclein toxicity (2021)](https://doi.org/10.1002/mds.28412)

[He X, Zhang L, Yao Y, et al. SMAD5 and tau pathology in Alzheimer's disease (2019)](https://doi.org/10.1111/acel.12984)

[Zhang Y, Lin S, Cheng X, et al. BMP signaling in neural stem cell biology (2022)](https://doi.org/10.1186/s13287-022-02918-9)

[Morimoto Y, Kikuchi H, Ishida T, et al. SMAD5 deficiency in dopaminergic neurons (2021)](https://doi.org/10.1002/jnr.24856)

[Yang R, Liu H, Wang P, et al. BMP7-SMAD5 axis in neuroprotection (2023)](https://doi.org/10.1016/j.brainresbull.2023.01.005)

📖 View canonical wiki page →

Related Entities

SMAD5

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-smad5
kg_node_id	SMAD5
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-3841567dba8f
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-smad5'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

25%

Debates

0

Incoming

5

Outgoing

10

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

SMAD5 — SMAD Family Member 5

SMAD5 — SMAD Family Member 5

SMAD5 — SMAD Family Member 5

Overview

SMAD5 — SMAD Family Member 5

SMAD5 — SMAD Family Member 5

Overview

Gene Structure and Expression

Genomic Organization

Protein Domain Architecture

Tissue Expression

Canonical BMP-SMAD5 Signaling Pathway

Signal Initiation

Receptor Complex Formation

SMAD5 Activation and Nuclear Translocation

Role in the Nervous System

Neural Stem Cell Biology

Dopaminergic Neuron Development

Synaptic Plasticity and Memory

Neuroprotection

Disease Associations

Alzheimer's Disease

Parkinson's Disease

Other Neurodegenerative Conditions

Molecular Mechanisms in Neurodegeneration

Mitochondrial Dysfunction

Neuroinflammation

Protein Aggregation

Cellular Stress Responses

Therapeutic Implications

Drug Development Targets

Gene Therapy Approaches

Biomarker Potential

Challenges

Non-Canonical SMAD5 Signaling

MAPK Pathway Interactions

PI3K/AKT Pathway

Rho GTPase Pathways

Interactions with Other Proteins

SMAD Family Interactions

Transcriptional Co-factors

Signaling Pathway Cross-talk

Genetic Variants and Polymorphisms

Known Variants

Disease Associations

Experimental Models and Research Tools

Mouse Models

Cell Culture Models

Small Molecule Modulators

Clinical and Therapeutic Considerations

Clinical Biomarkers

Therapeutic Strategies

Key Publications

External Links

Related Pages

References

💬 Discussion